FindTrial
Sign In

Development of an Endoscopic and Robotic-Assisted Surgical Strategy for Low-Risk Patients

A Clinical Study on Stratified and Individualized Surgical Treatment and Postoperative Management of Differentiated Thyroid Carcinoma (DTC): Development of an Endoscopic and Robotic-Assisted Surgical Strategy for Low-Risk Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113602
Enrollment
Unknown
Registered
2025-12-01
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tthyroid cancer

Interventions

Experimental group:Endoscopic thyroidectomy
Control Group:Open thyroidectomy
Observation group:None

Sponsors

Sichuan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years. 2.Unilateral lesion of differentiated thyroid carcinoma (DTC), staged as cT1–T2N1aM0. 3.Eastern Cooperative Oncology Group (ECOG) performance status score of 0–1.

Exclusion criteria

Exclusion criteria: 1.History of thyroid surgery. 2.Clinical evidence of lateral neck lymph node metastasis (cN1b) or distant metastasis (cM1). 3.Bilateral or multifocal thyroid carcinoma; aggressive histological subtypes. 4.Severe comorbidities. Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frame
Recurrence-Free Survival (RFS);Quality of Life(QoL);Incidence of Complications;—

Countries

China

Contacts

Public ContactChao Li

Sichuan Cancer Hospital

lichao@scszlyy.org.cn+86 135 4123 3090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026